Advertisement

Topics

Encore, A Quintiles Company Company Profile

09:12 EDT 25th September 2018 | BioPortfolio

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President Tom Niehaus, the company provides consulting services and solutions that assist its expanding client base with a wide range of HIT strategy, advisory, implementation, process-redesign, and optimization initiatives. Encore focuses on capturing the right data at the right time, establishing analytical capabilities that meet the evolving information and reporting needs of healthcare providers to document and improve clinical and operational performance. To learn more about Encore, please visit www.encorehealthresources.com.


News Articles [65 Associated News Articles listed on BioPortfolio]

Conatus completes enrolment in ENCORE-PH trial

Conatus Pharmaceuticals has completed patient enrolment in ENCORE-PH trial, a Phase IIb study evaluating the safety, dosing and efficacy of...Read More... The post Conatus completes enrolment in ENCOR...

Syndax Announces Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination ...

ENCORE 601 is a Phase 1b/2 trial evaluating the efficacy and safety of entinostat in combination with pembrolizumab across multiple cohorts of PD-(L)1 treatment-naïve Read more...

Quintiles Transnational Holdings Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 17022018] Prices from USD $350

Quintiles Transnational Holdings Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Quintiles Transnational Holdings Inc. Mergers Acquisitions MA, Partne...

ÉVALUATION de la DOULEUR PÉDIATRIQUE : Un défi en cas de troubles complexes et neurologiques

L’évaluation de la douleur chez le petit enfant, encore incapable de s’exprimer et de la décrire avec des mots, ou encore chez des enfants présentant des comorbidités complexes, est un défi d...

$SNDX Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) in #NSCLC https://www.prnewswire.com/news-releases/syndax-announces-updated-results-from-phase-2-encore-601-trial-of-entinostat-in-combination

$SNDX Updated Results from Phase 2 ENCORE 601 Trial of Entinostat in Combination with KEYTRUDA® (pembrolizumab) in #NSCLC https://www.prnewswire.com/news-releases/syndax-announces-updated-resul...

NovaQuest: Principles and Strategies

In this exclusive interview, Fintan Walton talks to Ben Cons, Vice President of NovaQuest, about NovaQuest’s functions and operations, and how these differ from those of its parent company, Quintile...

Syndax Pharmaceuticals: Elucidating The Results Of The Phase 2 ENCORE 601 Trial

Endologix Reports Positive Results from Global ENCORE Analysis with Polymer Endovascular Aneurysm Repair (EVAR) Using Ovation Abdominal Stent Graft Systems

Company to Host Investor Conference Call on March 20, 2018 at 8:30 a.m. ET Endologix, Inc. (Nasdaq:ELGX), a developer and marketer of innovative treatments for aortic d...

PubMed Articles [38 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Inequality in total fertility rates and the proximate determinants of fertility in 21 sub-Saharan African countries.

In this paper, we examine the inequality in the dynamics of the total fertility rate within 21 sub-Saharan African countries by wealth quintiles. We also examine the associated inequality within each ...

A Man (or a Woman) is Known by the Company He/She Keeps.

High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study.

Because several studies have implicated serotonin as a regulator of bone mass, we here explore its potential association on fracture risk and falls, as on bone mineral density (BMD) and muscle strengt...

McGoldrick, M. (2016). The genogram casebook: A clinical companion to genograms: Assessment and intervention. New York, NY: W.W. Norton & Company, 304 pp., $32.00.

Clinical Trials [96 Associated Clinical Trials listed on BioPortfolio]

3DKnee™ System vs. the MJS Knee System

The purpose of this study is to compare the survivorship and efficacy of the Encore 3DKnee™ system with that of the Encore MJS™ Knee System in a group of 600 patients for whom data col...

Retrospective Encore Reverse Shoulder Prosthesis Study

The purpose of this study is to evaluate the survivorship and efficacy of the Encore Reverse Shoulder Prosthesis in a group of no more than 50 subjects for whom data collection has already...

Efficacy of the CLP® Hip - Retrospective

The purpose of this study is to evaluate the survivorship and efficacy of the Encore CLP® Hip stem in a group of no more than 200 patients from whom data has already been collected.

Retrospective Study of the Linear™ Hip

The purpose of this study is to evaluate the use and efficacy of the Encore Linear™ Hip System in a group of 200 patients for whom data has already been collected.

Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia

The goal of this project is to evaluate an innovative psychosocial intervention package that will incorporate evidence-based treatment strategies to target the affective-motivational defic...

Companies [1470 Associated Companies listed on BioPortfolio]

Encore, A Quintiles Company

Encore, A Quintiles Company, is an award-winning leader in health-information technology services and solutions. Founded in 2009 and led by Encore CEO Dana Sellers and President T...

Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of mo...

Quintiles Transnational Holdings Inc.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more ...

Quintiles and IMS Health

Quintiles (NYSE:Q) helps biopharma and other healthcare companies improve their probability of success by connecting insights from our deep scientific, therapeutic and analytics e...

Encore Health Resources

Encore Health Resources, founded by healthcare veterans Ivo Nelson and Dana Sellers, provides information technology consulting services to the provider segment of the healthcare ...

More Information about "Encore, A Quintiles Company" on BioPortfolio

We have published hundreds of Encore, A Quintiles Company news stories on BioPortfolio along with dozens of Encore, A Quintiles Company Clinical Trials and PubMed Articles about Encore, A Quintiles Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Encore, A Quintiles Company Companies in our database. You can also find out about relevant Encore, A Quintiles Company Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record